Kerala Ayurveda Eyes ₹200 Cr Sales In FY27, Targets ₹1,000 Cr By 2030

CW Bureau ·

Kerala Ayurveda Ltd (KAL) is targeting consolidated revenue of ₹200 crore in FY27, representing around 38% growth over FY26, as it seeks to build a ₹1,000-crore enterprise by 2030 under its Vision 2030 strategy.

Operating revenue is targeted to grow by around 50% in FY27, with the company focusing on its Global E-Product, Global Health Services, US Academy and Wellness businesses as key engines of future growth.

Global businesses drive expansion

Kerala Ayurveda, Chairman, Ramesh Vangal, said in a letter to shareholders that the company’s long-term strategy remains anchored in Vision 2030, with increasing focus on businesses offering scalable and sustainable growth potential.

“Our focus is increasingly concentrated on businesses where we see the greatest potential for scalable and sustainable growth — particularly our Global E-Product and Health Services businesses, supported by our US Academy and Wellness operations,” he said.

Over the past two years, KAL has deliberately invested ahead of growth, strengthening its talent base, digital capabilities, manufacturing and service infrastructure, marketing platforms and working capital capacity.

Investments begin to gain traction

“The rationale behind these investments has been straightforward: to build the capabilities today that can support significantly larger businesses tomorrow,” Vangal said, adding that FY26 provided encouraging evidence that these capabilities were beginning to gain traction.

KAL witnessed growth across key businesses in FY26, including Global E-Product, US e-commerce, Global Health Services, US Academy and Wellness Centre operations.

Key engines of future expansion

“These businesses are increasingly becoming important engines of KAL’s growth,” Vangal said. Together, they enable the company to participate in the expanding global demand for Ayurveda, preventive healthcare and holistic wellness.

The company remains confident about the long-term potential of Ayurveda and its ability to participate meaningfully in its global growth. Vangal said the foundation for the next phase had been built, with the businesses demonstrating encouraging momentum.

FY27 revenue targets

For FY27, KAL is targeting ₹53 crore in revenue from Global E-Product, ₹58 crore from Global Health Services and ₹40 crore from its US Academy and Wellness Centre.

“Our growth ambition is therefore substantial. But equally important is the quality of this growth,” Vangal said, stressing that the next stage would focus on improving productivity from investments already made.

Focus shifts to profitability

“The task before us now is to execute with greater discipline and consistency, convert scale into operating leverage and translate revenue growth into sustainable profitability,” Vangal said.

The company plans to focus on profitable growth, operating efficiency and productivity, working-capital discipline and stronger cash conversion, while directing investments towards businesses with high growth potential.

Capital discipline takes priority

“We must continue to grow, but growth must increasingly be accompanied by stronger margins, disciplined capital deployment and improved cash generation,” Vangal said.

KAL will also continuously evaluate the returns generated from every incremental investment as it seeks to scale businesses that have demonstrated potential.

Building a stronger enterprise

The company’s strategy will also emphasis simplification and integration, with the objective of creating an enterprise that is larger, stronger, more resilient and financially sustainable.

Vangal said the aspiration was not merely to create a larger Kerala Ayurveda, but a better one that combines its heritage with the capabilities of a modern global enterprise.

FY27 seen as pivotal year

“FY27 is expected to be a pivotal year,” Vangal said, adding that the company’s focus would be on converting the momentum in its growth engines into profitable and sustainable growth.

He said the company had a long journey ahead, but its direction was clear, with a stronger platform and growth engines gaining momentum.

Technology and efficiency in focus

The next stage of the strategy will focus on extracting greater productivity from investments already made, improving working-capital efficiency, exercising tighter cost discipline and strengthening the underlying economics of each business.

“Our aspiration is not simply to create a larger Kerala Ayurveda. It is to create a better Kerala Ayurveda—a business that combines the strength of its heritage with the capabilities of a modern global enterprise and delivers sustainable value to all its stakeholders,” Vangal said.